ArgenTAG (Pre-Seed)

Funding Details
Date Award
May 13, 2024
Vertical
Biopharma
Funding URL
View Funding Page

Company Info
Founders
Leandro Ciappina, Pilar Bulacio, Elizabeth Tapia, Ignacio Labari, Joaquin Ezpeleta, SofĂ­a Lavista Llanos, Martina Fernandez
Company Description
ArgenTAG has developed the first truly scalable single-cell solution for long-read sequencers. The company has fundamentally changed the economics of single-cell sequencing by enabling single-cell sequencing to be performed on cheaper 3rd generation long-read DNA sequencers. This paradigm shift will allow the democratization of single-cell sequencing, profoundly affecting how biomedical research is performed and enabling the invention of new long-read applications.
Market
Human Health
Location
Argentina

Links
Back to Home Back to Biopharma Deals View Funding Announcement